Published in Lancet Oncol on August 01, 2008
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci (2010) 3.35
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer (2012) 2.41
IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res (2011) 2.08
Mechanical compression drives cancer cells toward invasive phenotype. Proc Natl Acad Sci U S A (2011) 1.84
Learning therapeutic lessons from metastasis suppressor proteins. Nat Rev Cancer (2009) 1.69
Metastatic tumors to the jaws and oral cavity. J Oral Maxillofac Pathol (2013) 1.47
Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol (2010) 1.29
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases. Cancer Lett (2010) 1.18
Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. Am J Pathol (2011) 1.16
Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion. Cancer Res (2011) 1.16
Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery. Cell Cycle (2013) 1.07
Tumor-derived exosomes: A message delivery system for tumor progression. Commun Integr Biol (2014) 0.99
Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4. Cell Cycle (2013) 0.97
A river model to map convergent cancer evolution and guide therapy in RCC. Nat Rev Urol (2015) 0.91
The landscape of metastatic progression patterns across major human cancers. Oncotarget (2015) 0.91
Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients. Biomed Res Int (2014) 0.90
Effects of iron deficiency and iron overload on angiogenesis and oxidative stress-a potential dual role for iron in breast cancer. Free Radic Biol Med (2010) 0.89
Circulating tumor cells in gastrointestinal malignancies: current techniques and clinical implications. J Oncol (2009) 0.87
Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl Oncol (2010) 0.86
Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix. Int J Breast Cancer (2011) 0.85
Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens. Childs Nerv Syst (2012) 0.84
The role of EMT and MET in cancer dissemination. Connect Tissue Res (2015) 0.84
Cross-species proteomics reveals specific modulation of signaling in cancer and stromal cells by phosphoinositide 3-kinase (PI3K) inhibitors. Mol Cell Proteomics (2014) 0.83
Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen. Childs Nerv Syst (2013) 0.83
The Contribution of Angiogenesis to the Process of Metastasis. Cancer J (2015) 0.80
The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers. BMC Cancer (2013) 0.80
AIP1 Expression in Tumor Niche Suppresses Tumor Progression and Metastasis. Cancer Res (2015) 0.79
A link between premenopausal iron deficiency and breast cancer malignancy. BMC Cancer (2013) 0.79
The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells. Crit Rev Immunol (2010) 0.79
MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion. Oncotarget (2016) 0.78
Breast cancer causes and treatment: where are we going wrong? Breast Cancer (Dove Med Press) (2013) 0.78
Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma. Stem Cells Int (2016) 0.77
Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst (2011) 0.77
Multicompartment metabolism in papillary thyroid cancer. Laryngoscope (2015) 0.77
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells. Clin Exp Metastasis (2016) 0.77
Role of Glycans in Cancer Cells Undergoing Epithelial-Mesenchymal Transition. Front Oncol (2016) 0.76
Characterization of highly proliferative secondary tumor clusters along host blood vessels in malignant glioma. Mol Med Rep (2015) 0.75
Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management. Hum Vaccin Immunother (2016) 0.75
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. Int J Oncol (2016) 0.75
Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer. Cell Death Dis (2016) 0.75
Statement on scientific publication and security. Science (2003) 3.04
Statement on the consideration of biodefence and biosecurity. Nature (2003) 2.09
Uncensored exchange of scientific results. Proc Natl Acad Sci U S A (2003) 1.73
Nullomers: really a matter of natural selection? PLoS One (2007) 1.67
Incorporating appropriate technology into North American schools of public health. Rev Panam Salud Publica (2006) 1.28
Regulatory and reimbursement innovation. Sci Transl Med (2013) 0.79
The globalization of US medical countermeasure production and its implications for national security. Biosecur Bioterror (2012) 0.75
Perspective from the founding editors. Preface. Adv Drug Deliv Rev (2012) 0.75
Patents, ethics and improving healthcare. Bull Med Ethics (1997) 0.75
The National Biomarker Development Alliance accelerating the translation of biomarkers to the clinic. Biomark Med (2014) 0.75